Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 3670348)

Published in N Engl J Med on November 12, 1987

Authors

L A Lettau1, J G McCarthy, M H Smith, S C Hadler, L J Morse, T Ukena, R Bessette, A Gurwitz, W G Irvine, H A Fields

Author Affiliations

1: Hepatitis Branch, Centers for Disease Control, Atlanta, GA 30333.

Articles by these authors

The molecular basis of the specific anti-influenza action of amantadine. EMBO J (1985) 7.08

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med (1986) 4.51

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (1998) 4.19

Antimicrobial treatment of pertussis. J Pediatr (1969) 3.77

The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med (1982) 3.69

Prospective randomised comparison of external dacryocystorhinostomy with and without silicone intubation. Br J Ophthalmol (2009) 3.51

Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA (1990) 3.41

Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA (1989) 3.39

Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis (1991) 3.29

Health, homelessness, and poverty. A study of clinic users. Arch Intern Med (1990) 3.14

Hepatitis A in day-care centers. A community-wide assessment. N Engl J Med (1980) 3.01

Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis (1982) 2.96

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol (1988) 2.84

Spontaneous mutation and parental age in humans. Am J Hum Genet (1987) 2.37

Seroepidemiology of hepatitis B virus infection in the United States. 1976 to 1980. Am J Med (1989) 2.30

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. Pediatrics (1997) 2.25

Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health (1985) 2.14

Genetic diversity in natural populations of a soil bacterium across a landscape gradient. Proc Natl Acad Sci U S A (1988) 2.09

Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother (1986) 2.04

Development of a plaque assay for a cytopathic, rapidly replicating isolate of hepatitis A virus. J Med Virol (1987) 1.89

The carrier state in pertussis. Am J Epidemiol (1968) 1.86

Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA (1992) 1.85

Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine (1989) 1.80

Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay. J Clin Microbiol (1977) 1.80

Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis (1986) 1.78

Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population. JAMA (1989) 1.77

Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med (1984) 1.74

Risk factors for hepatitis A in day-care centers. J Infect Dis (1982) 1.66

Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol (1992) 1.66

The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol (1987) 1.66

Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol (1979) 1.64

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64

Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Experience of the first three years. Am J Epidemiol (1988) 1.63

Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. Am J Med (1984) 1.61

Radiocesium in fish from the Savannah River and Steel Creek: potential food chain exposure to the public. Risk Anal (2001) 1.60

Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus. J Clin Microbiol (1979) 1.60

Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg (1997) 1.59

Inducible repair of phosphotriesters in Escherichia coli. Proc Natl Acad Sci U S A (1983) 1.58

Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis (2001) 1.57

Tuberculosis in children. Pediatr Infect Dis J (1988) 1.57

Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53

Biochemical polymorphism and systematics in the genus Peromyscus. VI. The boylii species group. J Mammal (1974) 1.52

Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis (1989) 1.51

Parathyroid hormone-secreting renal carcinoma associated with hypercalcemia and metabolic alkalosis. Ann Intern Med (1965) 1.51

Effect of immunoglobulin on hepatitis A in day-care centers. JAMA (1983) 1.51

Septicemia due to Klebsiella pneumoniae originating from a hand-cream dispenser. N Engl J Med (1967) 1.50

Health care for the homeless: a family medicine perspective. Am Fam Physician (1994) 1.49

Genic heterozygosity in a population of Eutamias panamintinus. J Mammal (1973) 1.48

A comparison of alveolar macrophages and pulmonary surfactant(?) obtained from the lungs of human smokers and nonsmokers by endobronchial lavage. Anat Rec (1969) 1.45

Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens. J Clin Microbiol (1984) 1.43

Hepatitis B infection in the United States. Recent trends and future strategies for control. Am J Med (1989) 1.43

Foodborne hepatitis A: evidence that microwaving reduces risk? J Infect Dis (1990) 1.43

Do intestinal parasites require oxygen? Nature (1969) 1.43

The Holy Cross college football team hepatitis outbreak. JAMA (1972) 1.42

Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest (1980) 1.42

Immunization of adolescents. Am Fam Physician (1997) 1.42

The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg (1974) 1.39

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus. Virology (2001) 1.39

Measles surveillance--United States, 1991. MMWR CDC Surveill Summ (1992) 1.38

ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain. Blood (2000) 1.38

Craniofacial shortening by contraction osteogenesis: an experimental model. Plast Reconstr Surg (2000) 1.38

The three-dimensional cephalogram: theory, technique, and clinical application. Am J Orthod Dentofacial Orthop (1988) 1.37

The "back to sleep campaign" and deformational plagiocephaly: is there cause for concern? J Craniofac Surg (1996) 1.36

Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J Infect Dis (1975) 1.35

Retracted High levels of genetic change in rodents of Chernobyl. Nature (1996) 1.35

Complete sequencing of a gibbon hepatitis B virus genome reveals a unique genotype distantly related to the chimpanzee hepatitis B virus. Virology (1996) 1.34

Cleavage of LexA repressor. Methods Enzymol (1994) 1.33

Detection and characterisation of swine hepatitis E virus in New Zealand. J Med Virol (2001) 1.32

Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis (1983) 1.32

Complement resistance-related traits among Escherichia coli isolates from apparently healthy birds and birds with colibacillosis. Avian Dis (2000) 1.32

Congenital infiltrating lipomatosis of the face: clinicopathologic evaluation and treatment. Plast Reconstr Surg (1983) 1.32

The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers. Lab Invest (1971) 1.32

Serologic investigation of an outbreak of hepatitis A in a rural day-care center. Am J Public Health (1983) 1.30

Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells. J Clin Microbiol (1986) 1.29

Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion. J Bone Miner Res (1997) 1.29

Congenital muscular torticollis and the associated craniofacial changes. Plast Reconstr Surg (2000) 1.29

Epitope mapping in proteins of hepatitis E virus. Virology (1993) 1.25

Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%. Antiviral Res (1999) 1.24

Lethal outbreak of hepatitis B in a dental practice. JAMA (1986) 1.24

Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987. JAMA (1990) 1.24

Immunodominant antigenic regions in a structural protein of the hepatitis E virus. Virology (1994) 1.22

Hand lotions--a potential nosocomial hazad. N Engl J Med (1968) 1.21

Changes in cell surface and cortical cytoplasmic organization during early embryogenesis in the preimplantation mouse embryo. J Cell Biol (1977) 1.20

Occupational risk of hepatitis B infection in hospital workers. Infect Control (1985) 1.20

Isolation, characterization, and pathogenicity studies of a bovine respiratory syncytial virus. Arch Virol (1975) 1.19

A Community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol (1986) 1.18

Are booster doses of hepatitis B vaccine necessary? Ann Intern Med (1988) 1.17

The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol (1990) 1.16

A multifocal outbreak of hepatitis A traced to commercially distributed lettuce. Am J Public Health (1990) 1.16

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis (1998) 1.16

Transmission of hepatitis B with resultant restriction of surgical practice. JAMA (1986) 1.16

ACUTE PANCREATITIS: AN ANALYSIS OF EIGHTY-EIGHT CASES WITH ESPECIAL REFERENCE TO DIAGNOSIS. Ann Surg (1929) 1.15

The preparation and characterization of anti-peptide heteroantisera recognizing subregions of the intracytoplasmic domain of class I H-2 antigens. Mol Immunol (1986) 1.15

Volumetric quantification of intracranial and ventricular volume following cranial vault remodeling: a preliminary report. Plast Reconstr Surg (1987) 1.13

IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein. J Med Virol (1996) 1.12

Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis (1992) 1.12

Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics (1969) 1.12